Robert Parrick
Internal Medicine · Fountain Inn, SCNPI 1679643910
Payments from drug & device makers
Across 148 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$423
- AbbVie$333
- Amgen$284
- Novartis$220
- Boehringer Ingelheim$155
- Lilly USA, LLC$108
- plus $714 from 20 others
What the payments were for
- Food & beverage$2,236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $423 |
| AbbVie(2 entities) | 26 | $333 |
| Amgen | 13 | $284 |
| Novartis | 14 | $220 |
| Boehringer Ingelheim | 11 | $155 |
| Lilly USA, LLC | 8 | $108 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $84 |
| Abbott | 4 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Dexcom, Inc. | 4 | $60 |
| Merck | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| GSK | 3 | $41 |
| Johnson & Johnson | 3 | $38 |
| Ironwood Pharmaceuticals, Inc | 2 | $28 |
| Bayer | 2 | $26 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| AstraZeneca | 2 | $23 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$125
How this compares
$2,236 in reported general payments places this provider in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $51,386 |
| JardianceEmpagliflozin | 17 | $23,285 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $779 |
| Gabapentin | 41 | $763 |
| Atorvastatin Calcium | 58 | $566 |
| Losartan Potassium | 31 | $323 |
| Omeprazole | 22 | $285 |
| Metoprolol Succinate | 22 | $248 |
| Duloxetine Hcl | 12 | $221 |
| Amlodipine Besylate | 38 | $217 |
| Levothyroxine Sodium | 24 | $191 |
| Escitalopram Oxalate | 23 | $169 |
| Fluticasone Propionate | 12 | $142 |
| Carvedilol | 14 | $139 |
| Celecoxib | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $155 | $23,28517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Fountain Inn
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
- Jerry BackNorth Charleston$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.